---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-166939"
form_type: "8-K"
ticker: "RVMD"
cik: "0001628171"
company_name: "Revolution Medicines, Inc."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:28:14.476924+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Revolution Medicines annual meeting votes approve all three proposals

## Summary
- Elected Class I directors: Elizabeth McKee Anderson (107.1M for), Flavia Borellini (107.3M for), Lorence Kim (97.4M for); broker non-votes 17.7M.
- Ratified PricewaterhouseCoopers as independent auditor for FY2024: 148.1M for, 9.9K against, 67.4K abstentions.
- Approved non-binding advisory vote on executive compensation: 128.9M for, 1.6M against, 27K abstentions; broker non-votes 17.7M.

## SEC filing metadata
- accession: 0001193125-24-166939
- form_type: 8-K
- ticker: RVMD
- cik: 0001628171
- company_name: Revolution Medicines, Inc.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628171/000119312524166939/0001193125-24-166939-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628171/000119312524166939/d853953d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-166939
- JSON: https://secwatch.observer/filing/0001193125-24-166939.json
- Plain text: https://secwatch.observer/filing/0001193125-24-166939.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.